Acute Migraine

Neurology

Prevalence

15000.0 / 100K

Incidence

1500.0 / 100K/yr

4 drugs in development·4 companies·0 clinical trials

Drug Pipeline by Phase

Phase 2(1)
DrugCompany
pur3100Pulmatrix, Inc. (PULM)

Compare drugs

rizaport vs treximetrizaport vs pur3100rizaport vs prochlorperazine and benadryl IV

Frequently asked questions

How many drugs are in development for Acute Migraine?

BioSniper tracks 4 drugs in development for Acute Migraine across 4 companies.

What is the prevalence of Acute Migraine?

The estimated prevalence of Acute Migraine is approximately 15000.0 per 100,000 population.

Deep-dive into Acute Migraine

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Acute Migraine — Drugs in Development & Clinical Trials | BioSniper